In placebo-controlled trials, cholelithiasis was reported in 1.5% and 0.4% of patients treated with Ozempic injection 0.5 mg and 1 mg, respectively, and not reported in placebo-treated patients
The other is a daily pill with a strict 30-minute fast
Recent Findings Beyond weight reduction, GLP-1RAs have shown positive cardiovascular outcomes in patients with elevated ASCVD risk, heart failure with preserved ejection fraction, obstructive sleep apnea, blood pressure, and dyslipidemia
If youve been curious about GLP-1s but hesitant about side effects or high doses, Low Dose therapy might be the balance youve been looking for
Some diabetes medications, including sulfonylureas and insulin, may interact with GLP-1 medications and increase the risk of hypoglycemia
The medication improves insulin secretion, reduces glucagon release, and slows gastric emptying, allowing for better glycaemic control when carbohydrates are consumed